Shangqi Yang

1.7k total citations
74 papers, 1.2k citations indexed

About

Shangqi Yang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shangqi Yang has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 39 papers in Cancer Research and 20 papers in Surgery. Recurrent topics in Shangqi Yang's work include MicroRNA in disease regulation (31 papers), Cancer-related molecular mechanisms research (31 papers) and Circular RNAs in diseases (30 papers). Shangqi Yang is often cited by papers focused on MicroRNA in disease regulation (31 papers), Cancer-related molecular mechanisms research (31 papers) and Circular RNAs in diseases (30 papers). Shangqi Yang collaborates with scholars based in China, Hong Kong and United States. Shangqi Yang's co-authors include Yongqing Lai, Yaoting Gui, Liangchao Ni, Xiangming Mao, DUQUN CHEN, Lü Jin, ZHENGMING SU, Zuhu Yu, Xiang Pan and Tao He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Life Sciences and Applied Soft Computing.

In The Last Decade

Shangqi Yang

73 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shangqi Yang China 21 817 735 195 175 81 74 1.2k
Fu‐Xing‐Zi Li China 17 798 1.0× 433 0.6× 96 0.5× 80 0.5× 41 0.5× 32 1.2k
Yozo Mitsui Japan 18 375 0.5× 236 0.3× 311 1.6× 155 0.9× 169 2.1× 66 864
Chunjiang Fu China 15 555 0.7× 277 0.4× 67 0.3× 170 1.0× 171 2.1× 38 964
Barbara Guertl Austria 11 643 0.8× 227 0.3× 85 0.4× 123 0.7× 104 1.3× 17 1.0k
Dechao Feng China 18 452 0.6× 316 0.4× 472 2.4× 215 1.2× 215 2.7× 115 1.1k
Guokun Wang China 17 570 0.7× 428 0.6× 144 0.7× 77 0.4× 79 1.0× 36 848
Jose L. Viñas Canada 13 549 0.7× 272 0.4× 70 0.4× 114 0.7× 35 0.4× 20 895
Wentao Liu China 14 270 0.3× 124 0.2× 231 1.2× 145 0.8× 83 1.0× 50 614
Su‐Kang Shan China 18 636 0.8× 337 0.5× 89 0.5× 85 0.5× 37 0.5× 34 1.0k
Jianguo Shi China 16 288 0.4× 154 0.2× 84 0.4× 91 0.5× 123 1.5× 48 605

Countries citing papers authored by Shangqi Yang

Since Specialization
Citations

This map shows the geographic impact of Shangqi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangqi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangqi Yang more than expected).

Fields of papers citing papers by Shangqi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shangqi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangqi Yang. The network helps show where Shangqi Yang may publish in the future.

Co-authorship network of co-authors of Shangqi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shangqi Yang. A scholar is included among the top collaborators of Shangqi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangqi Yang. Shangqi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fang, Xi Lin, Jiayu Zhang, et al.. (2023). Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation. Proceedings of the National Academy of Sciences. 120(41). e2221653120–e2221653120. 16 indexed citations
2.
Yang, Shangqi, et al.. (2023). Spatial feature embedding for robust visual object tracking. IET Computer Vision. 18(4). 540–556.
3.
Lin, Canbin, Zuwei Li, Peijie Chen, et al.. (2018). Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma. Life Sciences. 209. 481–489. 24 indexed citations
4.
Pan, Xiang, Jing Quan, Zuwei Li, et al.. (2018). miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma. Biomedicine & Pharmacotherapy. 102. 718–727. 16 indexed citations
5.
Chen, Peijie, Canbin Lin, Lü Jin, et al.. (2017). A Case Report of Giant Adrenal Ganglioneuroma. Urology Case Reports. 13. 37–38. 7 indexed citations
6.
Jin, Lü, Jing Quan, Xiang Pan, et al.. (2017). Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma. Molecular Medicine Reports. 16(5). 7072–7079. 27 indexed citations
7.
Jin, Lü, Xi Li, Yifan Li, et al.. (2017). Identification of miR-195-3p as an oncogene in RCC. Molecular Medicine Reports. 15(4). 1916–1924. 11 indexed citations
8.
Jin, Lü, Yifan Li, Tao He, et al.. (2017). Identification of miR-30b as an oncogene in renal cell carcinoma. Molecular Medicine Reports. 15(4). 1837–1846. 12 indexed citations
9.
Chen, Peijie, Lü Jin, Yu Yang, et al.. (2017). Bilateral primary adrenal diffuse large B cell lymphoma without adrenal insufficiency: A case report and review of the literature. Molecular and Clinical Oncology. 7(1). 145–147. 4 indexed citations
10.
Lin, Canbin, Lü Jin, Yu Yang, et al.. (2017). Tuberous sclerosis-associated renal angiomyolipoma: A report of two cases and review of the literature. Molecular and Clinical Oncology. 7(4). 706–708. 4 indexed citations
11.
He, Tao, Jiaju Liu, Yifan Li, et al.. (2016). Left adrenal gland metastasis of breast invasive ductal carcinoma: A case report. Molecular and Clinical Oncology. 4(5). 859–862. 4 indexed citations
12.
He, Tao, Jia Hu, Yifan Li, et al.. (2016). Glomus tumor of the anterior urethra: A rare case report and review of the literature. Molecular and Clinical Oncology. 4(6). 1057–1059. 6 indexed citations
13.
CHEN, DUQUN, Bentao Shi, Lijun Zhou, et al.. (2015). Primary mesenchymal chondrosarcoma with bilateral kidney invasion and calcification in renal pelvis: A case report and review of the literature. Oncology Letters. 10(2). 1075–1078. 4 indexed citations
14.
Li, Yifan, DUQUN CHEN, Lü Jin, et al.. (2015). Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma. Oncology Letters. 11(2). 1235–1241. 32 indexed citations
15.
Yu, Zuhu, DUQUN CHEN, ZHENGMING SU, et al.. (2014). miR-886-3p upregulation in clear cell renal cell carcinoma regulates cell migration, proliferation and apoptosis by targeting PITX1. International Journal of Molecular Medicine. 34(5). 1409–1416. 13 indexed citations
16.
CHEN, DUQUN, Yifan Li, ZHENGMING SU, et al.. (2014). Identification of miR-125a-5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis. Molecular Medicine Reports. 11(2). 1278–1283. 18 indexed citations
17.
SU, ZHENGMING, Liangchao Ni, Zuhu Yu, et al.. (2014). MicroRNA-451a is associated with cell proliferation, migration and apoptosis in renal cell carcinoma. Molecular Medicine Reports. 11(3). 2248–2254. 32 indexed citations
18.
SU, ZHENGMING, Yadong Wang, Zuhu Yu, et al.. (2014). Bizarre leiomyoma of the scrotum: A case report and review of the literature. Oncology Letters. 7(5). 1701–1703. 4 indexed citations
19.
Lai, Yongqing, DUQUN CHEN, Zuhu Yu, Liangchao Ni, & Shangqi Yang. (2014). Non-functioning paraganglioma of the urinary bladder: A case report and review of the literature. Oncology Letters. 7(3). 891–893. 13 indexed citations
20.
Yu, Zuhu, Liangchao Ni, DUQUN CHEN, et al.. (2013). Identification of miR-7 as an oncogene in renal cell carcinoma. Journal of Molecular Histology. 44(6). 669–677. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fu‐Xing‐Zi Li Breakdown of academic impact, for papers by Yozo Mitsui Breakdown of academic impact, for papers by Chunjiang Fu Breakdown of academic impact, for papers by Barbara Guertl Breakdown of academic impact, for papers by Dechao Feng Breakdown of academic impact, for papers by Guokun Wang Breakdown of academic impact, for papers by Jose L. Viñas Breakdown of academic impact, for papers by Wentao Liu Breakdown of academic impact, for papers by Su‐Kang Shan Breakdown of academic impact, for papers by Jianguo Shi
Rankless by CCL
2026